Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Sherief Abd-Elsalam

Status: Enrolling

Conditions: Heart Failure

Treatments: Diagnostic Test: New york Heart Association Class I; Diagnostic Test: New york Heart Association Class II-IV

Study type: Interventional

Funder types: Other

Identifiers

NCT03772275

Heart failure

Details and patient eligibility

About

Clinical and Economic study of some new biomarkers in chronic heart failure.

Full description

The study aimed at evaluation of the clinical and economic value of some new biomarkers in chronic heart failure.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• NYHA-Class II-IV

Exclusion criteria

• Liver or renal dysfunction. --DM

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

New york Heart Association Class II-IV

Active Comparator group

Description:

New york Heart Association Class II-IV heart failure

Treatment:

Diagnostic Test: New york Heart Association Class II-IV

New york Heart Association Class I

Active Comparator group

Description:

New york Heart Association Class I with no heart failure

Treatment:

Diagnostic Test: New york Heart Association Class I